Valumeds Non-drowsy Allergy Relief Fexofenadine Hcl Tablet
NDC Package 82725-1202-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Valumeds Non-drowsy Allergy Relief Fexofenadine Hcl (fexofenadine hydrochloride) tablets is  adults and children 12 years of age and over take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor. This formulation utilizes a tablet delivery system. Marketed by Cabinet Health P.b.c., this product is identified by NDC 82725-1202 and is authorized under FDA application ANDA204097.

Identification & Billing

NDC Package Code
82725-1202-2
Package Description
200 TABLET in 1 BOTTLE
Product Code
82725-1202
11-Digit Billing Format
82725120202
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Valumeds Non-drowsy Allergy Relief Fexofenadine Hcl
Non-Proprietary Name
Fexofenadine Hydrochloride
Substance Name
Fexofenadine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
FEXOFENADINE HYDROCHLORIDE 180 mg/1
Pharmacologic Class
Usage Information
 adults and children 12 years of age and over take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor

Regulatory & Marketing

Labeler Name
Cabinet Health P.b.c.
Product Type
Human Otc Drug
FDA Application #
ANDA204097
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (82725-1202). Click a package code to view its specific billing and regulatory data.

82725-1202-1
100 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82725-1202-2 identifies a specific commercial package of 200 tablet in 1 bottle of Valumeds Non-drowsy Allergy Relief Fexofenadine Hcl, a human over the counter drug labeled by Cabinet Health P.b.c.. This tablet is formulated for oral use and contains fexofenadine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cabinet Health P.b.c. on November 01, 2025. The current certification is valid through December 31, 2027.

How is this Cabinet Health P.b.c. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82725120202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
82725-1202-2
11-Digit CMS (5-4-2)
82725-1202-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.